ArticlePloS one2015

The Frequency and Clinical Implication of ROS1 and RET Rearrangements in Resected Stage IIIA-N2 Non-Small Cell Lung Cancer Patients.

Sha Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.